Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Mariusz Tomaniak; P Chichareon; Yoshinobu Onuma; EN Deliargyris; K Takahashi; N Kogame; R Modolo; Chun-Chin Chang; T Rademaker-Havinga; RF Storey; GD Dangas; DL Bhatt; DJ Angiolillo; C Hamm; M Valgimigli; S Windecker; PG Steg; P Vranckx; PWJC Serruys

doi:10.1001/jamacardio.2019.3355

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Mariusz Tomaniak, P Chichareon, Yoshinobu Onuma, EN Deliargyris, K Takahashi, N Kogame, R Modolo, Chun-Chin Chang, T Rademaker-Havinga, RF Storey, GD Dangas, DL Bhatt, DJ Angiolillo, C Hamm, M Valgimigli, S Windecker, PG Steg, P Vranckx, PWJC Serruys

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

116 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1092-1101
Number of pages	10
Journal	JAMA Cardiology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1001/jamacardio.2019.3355
Publication status	Published - 2019

Research programs

EMC COEUR-09

Access to Document

10.1001/jamacardio.2019.3355

Cite this

Tomaniak, M., Chichareon, P., Onuma, Y., Deliargyris, EN., Takahashi, K., Kogame, N., Modolo, R., Chang, C.-C., Rademaker-Havinga, T., Storey, RF., Dangas, GD., Bhatt, DL., Angiolillo, DJ., Hamm, C., Valgimigli, M., Windecker, S., Steg, PG., Vranckx, P., & Serruys, PWJC. (2019). Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial. JAMA Cardiology, 4(11), 1092-1101. https://doi.org/10.1001/jamacardio.2019.3355

@article{3a46f7854bfe4f879831b811f226fc3f,

title = "Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial",

author = "Mariusz Tomaniak and P Chichareon and Yoshinobu Onuma and EN Deliargyris and K Takahashi and N Kogame and R Modolo and Chun-Chin Chang and T Rademaker-Havinga and RF Storey and GD Dangas and DL Bhatt and DJ Angiolillo and C Hamm and M Valgimigli and S Windecker and PG Steg and P Vranckx and PWJC Serruys",

year = "2019",

doi = "10.1001/jamacardio.2019.3355",

language = "Undefined/Unknown",

volume = "4",

pages = "1092--1101",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "11",

}

Tomaniak, M, Chichareon, P, Onuma, Y, Deliargyris, EN, Takahashi, K, Kogame, N, Modolo, R, Chang, C-C, Rademaker-Havinga, T, Storey, RF, Dangas, GD, Bhatt, DL, Angiolillo, DJ, Hamm, C, Valgimigli, M, Windecker, S, Steg, PG, Vranckx, P & Serruys, PWJC 2019, 'Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial', JAMA Cardiology, vol. 4, no. 11, pp. 1092-1101. https://doi.org/10.1001/jamacardio.2019.3355

TY - JOUR

T1 - Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

AU - Tomaniak, Mariusz

AU - Chichareon, P

AU - Onuma, Yoshinobu

AU - Deliargyris, EN

AU - Takahashi, K

AU - Kogame, N

AU - Modolo, R

AU - Chang, Chun-Chin

AU - Rademaker-Havinga, T

AU - Storey, RF

AU - Dangas, GD

AU - Bhatt, DL

AU - Angiolillo, DJ

AU - Hamm, C

AU - Valgimigli, M

AU - Windecker, S

AU - Steg, PG

AU - Vranckx, P

AU - Serruys, PWJC

PY - 2019

Y1 - 2019

U2 - 10.1001/jamacardio.2019.3355

DO - 10.1001/jamacardio.2019.3355

M3 - Article

C2 - 31557763

SN - 2380-6583

VL - 4

SP - 1092

EP - 1101

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 11

ER -